Purpose: Although data suggest that physical activity is associated with decreased insulin resistance, recommendations for exercise training are not specific for age or level of obesity. Therefore, we examined the influence of moderate-intensity (50% of V̇O2max) exercise training (MI) versus high-intensity (75% of V̇O2max) exercise training (HI) on insulin-stimulated glucose disposal (ISGD) in elderly individuals.
Methods: Following medical examinations, 21 overweight (body mass index = 29 ± 1 kg·m−2) elderly (74 ± 1 yr) subjects were randomized to 1) HI, 2) MI, or a 3) nonexercising control group. Subjects enrolled in HI or MI completed a 12-wk exercise training regimen designed to expend 1000 kcal·wk−1. ISGD was assessed using a hyperinsulinemic, euglycemic clamp pre- and postintervention. ISGD was corrected for hepatic glucose production (glucose Ra) using a constant rate infusion of [6,6-2H2]glucose and determined during the last 30 min of the clamp by subtracting glucose Ra from the exogenous glucose infusion rate. Nonoxidative glucose disposal was calculated using indirect calorimetry. Body composition testing was completed using dual energy x-ray absorptiometry.
Results: ISGD increased by approximately 20% with HI (Δ of 1.4 ± 0.5 mg·kg−1 FFM·min−1). However, ISGD did not change (Δ of −0.4 ± 0.1 mg·kg−1 FFM·min−1) with MI and was not different (Δ of −0.2 ± 0.1 mg·kg−1 FFM·min−1) in the control group. Nonoxidative glucose disposal increased with HI (Δ of 1.4 ± 0.5 mg·kg−1 FFM·min−1), but there was no change in nonoxidative glucose disposal with MI or in the control group. No change in body weight or percentage of body fat was observed in any group.
Conclusion: In weight-stable subjects, MI resulted in no change in ISGD, and the improvement in ISGD with HI was completely reliant on improvements in nonoxidative glucose disposal.
1Nutrition, Metabolism, and Exercise Laboratory, University of Arkansas for Medical Sciences, Little Rock, AR; 2Geriatric Research, Education, and Clinical Center, Central Arkansas Veterans Healthcare System, Little Rock, AR; and 3Pfizer Global Research and Development, New London, CT
Address for correspondence: Robert H. Coker, Ph.D., Nutrition, Metabolism, and Exercise Laboratory, DWR Institute on Aging, 4301 W. Markham, Slot 806, University of Arkansas for Medical Sciences, Little Rock, AR 72205; E-mail: firstname.lastname@example.org.
Submitted for publication May 2005.
Accepted for publication August 2005.